Atlas Trials

Qurgen Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qurgen Inc.

RecordFirmDate
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors (NCT06873659)Qurgen Inc.2025-02-26
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors (NCT05989724)Qurgen Inc.2023-09-19

Track Qurgen Inc. automatically

Every clearance here is in the API, with alerts when new ones post.